U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H18N4O.ClH
Molecular Weight 306.791
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FACINICLINE HYDROCHLORIDE

SMILES

Cl.O=C(N[C@@H]1CN2CCC1CC2)C3=NNC4=C3C=CC=C4

InChI

InChIKey=CMRLNEYJEPELSM-BTQNPOSSSA-N
InChI=1S/C15H18N4O.ClH/c20-15(14-11-3-1-2-4-12(11)17-18-14)16-13-9-19-7-5-10(13)6-8-19;/h1-4,10,13H,5-9H2,(H,16,20)(H,17,18);1H/t13-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C15H18N4O
Molecular Weight 270.3296
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Facinicline (MEM-63908 or R-4996) is a selective nicotinic alpha-7 receptor (α7nAChR) partial agonist. It also has properties of a serotonin 3 receptor antagonist. It has hydrochloride form: RG3487 (formerly MEM3454). Facinicline enhances DA efflux by nAChR stimulation, whereas ACh efflux is primarily mediated via 5-HT3 receptor antagonism. It improves cognition and sensorimotor gating in rodents. It has been tested in Alzheimer's disease and cognitive symptoms of schizophrenia.

Approval Year

PubMed

PubMed

TitleDatePubMed
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents.
2011 Jan
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.
2014 Jun
The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release.
2014 May
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:09:40 GMT 2023
Edited
by admin
on Sat Dec 16 11:09:40 GMT 2023
Record UNII
O6J463N18M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FACINICLINE HYDROCHLORIDE
Common Name English
N-((3S)-1-AZABICYCLO(2.2.2)OCT-3-YL)-1H-INDAZOLE-3-CARBOXAMIDE HYDROCHLORIDE
Systematic Name English
RG-3487
Code English
MEM 3454
Code English
1H-INDAZOLE-3-CARBOXAMIDE, N-(3S)-1-AZABICYCLO(2.2.2)OCT-3-YL-, MONOHYDROCHLORIDE
Systematic Name English
RG3487
Code English
1H-INDAZOLE-3-CARBOXAMIDE, N-(3S)-1-AZABICYCLO(2.2.2)OCT-3-YL-, HYDROCHLORIDE (1:1)
Systematic Name English
MEM-3454
Code English
Code System Code Type Description
CAS
677305-02-1
Created by admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
PRIMARY
CAS
909910-22-1
Created by admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
NO STRUCTURE GIVEN
ChEMBL
CHEMBL3544952
Created by admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
PRIMARY
DRUG BANK
DBSALT002602
Created by admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
PRIMARY
FDA UNII
O6J463N18M
Created by admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
PRIMARY
PUBCHEM
10380472
Created by admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
TARGET -> AGONIST
(.ALPHA.7 NACHR) IN VITRO DATA KI = 6 NM (R)
Related Record Type Details
ACTIVE MOIETY